Centogene N.V. (NASDAQ:CNTG) launched FilterTool, an advanced web-based application for genetic data interpretation.
The new FilterTool application integrates with Centogene’s CE-marked Software as a Service (SaaS) bioinformatics pipeline, CentoCloud, as an accessory.
It enables laboratories, medical experts, and bioinformaticians to display, filter, select, and classify relevant genetic variants identified by Next Generation Sequencing (NGS) data analysis.
It will allow CentoCloud users to visualize critical genetic variants of concern for any given patient. The FilterTool uses a multiomic dataset containing unique variants and insights from over 2,500 rare and neurodegenerative diseases and integrates less specialized common public databases.
Pairing FilterTool with Centogene’s CentoCloud SaaS bioinformatics pipeline utilizes a prioritization algorithm that delivers the top 25 most relevant variants responsible for patient symptoms from possibly tens of thousands.
Centogene’s FilterTool is one of the world’s only CE-marked In Vitro Diagnostic Regulation (IVDR 2017/746) filtering applications to support experts in genomic diagnostics following a new regulatory framework from the European Parliament last year.
Price Action: CNTG shares are up 14.1% at $1.86 at the last check Wednesday.
